U.S. Markets closed

Why This High-Growth Medtech Stock Might Cut Its 2019 Outlook

ALLISON GATLIN
Why This High-Growth Medtech Stock Might Cut Its 2019 Outlook

Boston Scientific will likely cut its 2019 outlook, an analyst said Monday after the Food and Drug Administration dealt the medical device company a pair of setbacks in March and April.